4//SEC Filing
Loury David J 4
Accession 0001209191-13-006630
CIK 0000949699other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 7:08 PM ET
Size
8.6 KB
Accession
0001209191-13-006630
Insider Transaction Report
Form 4
Loury David J
Vice President of Development
Transactions
- Exercise/Conversion
Common Stock
2013-02-05$2.76/sh+20,000$55,200→ 20,325 total - Sale
Common Stock
2013-02-05$70.58/sh−20,000$1,411,510→ 325 total - Exercise/Conversion
Stock Option (Right to Buy
2013-02-05−20,000→ 55,000 totalExercise: $2.76From: 2007-03-13Exp: 2017-03-13→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Sale of shares poursuant to a 10b5-1 plan adopted on December 21, 2012.
- [F2]The option shares vest in a series of 48 equal and successive monthly installments measured from 3/13/2007.
Documents
Issuer
PHARMACYCLICS INC
CIK 0000949699
Entity typeother
Related Parties
1- filerCIK 0001383004
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 7:08 PM ET
- Size
- 8.6 KB